Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase)

NCT04829435 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia
Gout

Interventions

DRUG: ALLN-346
DRUG: Placebo

Sponsor

Allena Pharmaceuticals